Solriamfetol enhances wakefulness and improves cognition and anxiety in a murine model of OSA is a research paper published in Sleep Medicine (2023). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: AG061824
NIA NIH HHS
Grant: RF1 AG061824
Jazz Pharmaceuticals
Grant: unidentified
unidentified
Jazz Pharmaceuticals
University of Missouri
Jazz Pharmaceuticals Inc Ewing
FWCI
1.69
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals